<?xml version="1.0" encoding="UTF-8"?>
<p>A group of eight informed and willing PD patients was formed for the initial trial. They formed a heterogeneous group of 48–75-year-old individuals with a 2–25-year history of the disease, diagnosed with moderate idiopathic PD, responsive to L-DOPA, some with an inadequate relief of symptoms, and others showing mild to severe secondary effects to the drug (dyskinesias).</p>
